Whole Body PET/MRI Provides One-Stop-Shop for Staging High-Risk Prostate Cancer Patients (VIDEO)

Society of Nuclear Medicine and Molecular Imaging

Caption

Dr. Andrei Gafita from Technical University Munich discusses new research showing that molecular imaging--specifically, PSMA PET/MR--performs as well as currently used tools and provides additional information on tumor location that could help guide treatment for prostate cancer patients. The research is featured in the December 2018 issue of The Journal of Nuclear Medicine.

Credit

<i>The Journal of Nuclear Medicine</i>

Usage Restrictions

Please give appropriate credit and indicate if changes were made.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.